Fig 1.
TriNetX search strategy that allowed the authors to narrow down the EMRs of an initial 73,346,583 patients into two propensity score matched 37,377-patient cohorts (N = 74,754) for direct comparison of adverse outcomes within 30, 60, 90, & 120 days of SARS-CoV-2-positive diagnosis.
Table 1.
Propensity score matching results, all factors were significantly different between the 2 cohorts prior to matching (p<0.0001).
Table 2.
Statistical analysis of adverse outcomes within 30 days of SARS-CoV-2-positive diagnosis.
Table 3.
Statistical analysis of adverse outcomes within 60 days of SARS-CoV-2-positive diagnosis.
Table 4.
Statistical analysis of adverse outcomes within 90 days of SARS-CoV-2-positive diagnosis.
Table 5.
Statistical analysis of adverse outcomes within 120 days of SARS-CoV-2-positive diagnosis.
Fig 2.
Significant adverse outcome trends 30–120 days (a), 60–120 days (b) & 90–120 days (c) (p<0.05). ** ICU Admissions Within 60 Days approaching significance (p = 0.0509, 95%).
Fig 3.
NNV to prevent adverse outcomes within 30–120 days, 60–120 days, and 90–120 days of SARS-CoV-2-positive diagnosis.